Ratings
0
Nobody has rated this yet. Be the first!
Works
5
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial
The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics
.png/500px-American_Academy_of_Arts_and_Sciences_(ancient_logo).png)
